Prostate Cancer Reports



Volume 3 Number 2
February 2015
Home > Prostate Cancer Reports > Volume 3, Year 2015 > Number 2, February

CONTENTS



Detection, diagnosis and evaluation
Epidemiology and risk factors
Etiology and pathogenesis
Integrative medicine
Prognosis and outcome
Quality of life
Treatment


DETECTION, DIAGNOSIS AND EVALUATION



Wang Y, Wan F, Xu L, Zhao N, Xu Z, Wang H, Wang G, Ye D, Guo J.
Is it Safe to Omit Baseline Bone Scan for Newly Diagnosed Prostate Cancer Patients?
Urol Int. 2015;94(3):342-6. doi: 10.1159/000368912. Epub 2015 Jan 29.
Abstract | Related citations

EPIDEMIOLOGY AND RISK FACTORS



Van Hemelrijck M, Folkvaljon Y, Adolfsson J, Akre O, Holmberg L, Garmo H, Stattin P.
Causes of death in men with localised prostate cancer: a nationwide, population-based study.
BJU Int. 2015 Jan 21. doi: 10.1111/bju.13059. [Epub ahead of print]
Abstract | Full text | Related citations

ETIOLOGY AND PATHOGENESIS



Rybak AP, Bristow RG, Kapoor A.
Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
Oncotarget. 2015 Feb 10;6(4):1900-19.
Abstract | Full text | Related citations

INTEGRATIVE MEDICINE



Red yeast rice

Chiu HW, Fang WH, Chen YL, Wu MD, Yuan GF, Ho SY, Wang YJ.
Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy.
PLoS One. 2012;7(7):e40462. doi: 10.1371/journal.pone.0040462. Epub 2012 Jul 3.
Abstract | Full text | Related citations


Hong MY, Henning S, Moro A, Seeram NP, Zhang Y, Heber D.
Chinese red yeast rice inhibition of prostate tumor growth in SCID mice.
Cancer Prev Res (Phila). 2011 Apr;4(4):608-15. doi: 10.1158/1940-6207.CAPR-10-0219. Epub 2011 Jan 28.
Abstract | Full text | Related citations


Hong MY, Seeram NP, Zhang Y, Heber D.
Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression.
J Med Food. 2008 Dec;11(4):657-66. doi: 10.1089/jmf.2007.0702.
Abstract | Related citations


Lapi F, Gallo E, Bernasconi S, Vietri M, Menniti-Ippolito F, Raschetti R, Gori L, Firenzuoli F, Mugelli A, Vannacci A.
Myopathies associated with red yeast rice and liquorice: spontaneous reports from the Italian Surveillance System of Natural Health Products.
Br J Clin Pharmacol. 2008 Oct;66(4):572-4. doi: 10.1111/j.1365-2125.2008.03224.x. Epub 2008 May 21.
Abstract | Full text | Related citations | News, News


Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G.
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.
Adv Ther. 2011 Dec;28(12):1105-13. doi: 10.1007/s12325-011-0082-5. Epub 2011 Nov 21.
Abstract | Related citations


Moyad MA, Klotz LH.
Statin Clinical Trial (REALITY) for prostate cancer: an over 15-year wait is finally over thanks to a dietary supplement.
Urol Clin North Am. 2011 Aug;38(3):325-31. doi: 10.1016/j.ucl.2011.05.002.
Abstract | Full text | Related citations

PROGNOSIS AND OUTCOME



Léon P, Seisen T, Cussenot O, Drouin SJ, Cattarino S, Compérat E, Renard-Penna R, Mozer P, Bitker MO, Rouprêt M.
Low circulating free and bioavailable testosterone levels as predictors of high-grade tumors in patients undergoing radical prostatectomy for localized prostate cancer.
Urol Oncol. 2015 Jan 13. pii: S1078-1439(14)00399-8. doi: 10.1016/j.urolonc.2014.11.010. [Epub ahead of print]
Abstract | Related citations


Malvezzi M, Bertuccio P, Rosso T, Rota M, Levi F, La Vecchia C, Negri E.
European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?
Ann Oncol. 2015 Apr;26(4):779-86. doi: 10.1093/annonc/mdv001. Epub 2015 Jan 26.
Abstract | Full text | Related citations


Martinez E, Daidone A, Gutierrez C, Pera J, Boladeras A, Ferrer F, Pino F, Suarez JF, Polo A, Guedea F.
Permanent seed brachytherapy for clinically localized prostate cancer: long-term outcomes in a 700 patient cohort.
Brachytherapy. 2015 Mar-Apr;14(2):166-72. doi: 10.1016/j.brachy.2014.11.015. Epub 2015 Jan 9.
Abstract | Related citations


Taguchi S, Fukuhara H, Kakutani S, Takeshima Y, Miyazaki H, Suzuki M, Fujimura T, Nakagawa T, Igawa Y, Kume H, Homma Y.
Risk factors for clinical metastasis in men undergoing radical prostatectomy and immediate adjuvant androgen deprivation therapy.
Asian Pac J Cancer Prev. 2014;15(24):10729-33.
Abstract | Full text | Related citations


Weiner AB, Patel SG, Eggener SE.
Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
Urol Oncol. 2015 Jan 23. pii: S1078-1439(14)00465-7. doi: 10.1016/j.urolonc.2014.12.012. [Epub ahead of print]
Abstract | Related citations

QUALITY OF LIFE



Stolzenburg JU, Graefen M, Kriegel C, Michl U, Martin Morales A, Pommerville PJ, Manning M, Büttner H, Henneges C, Schostak M.
Effect of surgical approach on erectile function recovery following bilateral nerve-sparing radical prostatectomy: an evaluation utilising data from a randomised, double-blind, double-dummy multicentre trial of tadalafil vs placebo.
BJU Int. 2015 Jan 5. doi: 10.1111/bju.13030. [Epub ahead of print]
Abstract | Related citations

TREATMENT



Cha EK, Eastham JA.
Chemotherapy and novel therapeutics before radical prostatectomy for high-risk clinically localized prostate cancer.
Urol Oncol. 2015 Jan 14. pii: S1078-1439(14)00444-X. doi: 10.1016/j.urolonc.2014.11.020. [Epub ahead of print]
Abstract | Related citations


Lei JH, Liu LR, Wei Q, Yan SB, Song TR, Lin FS, Yang L, Cao de H, Yuan HC, Xue WB, Lv X, Cai YC, Zeng H, Han P.
Systematic review and meta-analysis of the survival outcomes of first-line treatment options in high-risk prostate cancer.
Sci Rep. 2015 Jan 12;5:7713. doi: 10.1038/srep07713.
Abstract | Full text | Related citations


Murray LJ, Thompson CM, Lilley J, Cosgrove V, Franks K, Sebag-Montefiore D, Henry AM.
Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Phys Med Biol. 2015 Feb 7;60(3):1237-57. doi: 10.1088/0031-9155/60/3/1237. Epub 2015 Jan 15.
Abstract | Full text | Related citations


Safir IJ, Lian F, Alemozaffar M, Master VA.
Surgery for high-risk prostate cancer and metastatic prostate cancer.
Curr Probl Cancer. 2015 Jan-Feb;39(1):33-40. doi: 10.1016/j.currproblcancer.2014.11.006. Epub 2014 Nov 25.
Abstract | Related citations


Wilcox SW, Aherne NJ, McLachlan CS, McKay MJ, Last AJ, Shakespeare TP.
Is modern external beam radiotherapy with androgen deprivation therapy still a viable alternative for prostate cancer in an era of robotic surgery and brachytherapy: a comparison of Australian series.
J Med Imaging Radiat Oncol. 2015 Feb;59(1):125-33. doi: 10.1111/1754-9485.12275. Epub 2015 Jan 15.
Abstract | Full text | Related citations